Abstract: Provided herein are Brassica oleracea plants being resistant to the plant pathogen Albugo candida and wherein the resistance is encoded by one genomic region on chromosome. Also provided herein are methods for identifying the present Albugo candida resistance and to molecular markers for use in the present methods.

Abstract: The invention relates to anti-ganglioside GD2 antibodies that comprise an antibody variable domain and antibody constant domains, wherein the variable domain comprises a heavy and light chain variable region comprising respectively at least the CDR3 of the heavy chain variable region of antibody ch14.18 and at least the CDR3 of the light chain variable region of antibody ch14.18; and an IgA hinge and CH2 domain and to methods of treatment of subjects with a GD2 positive tumor, preferably neuroblastoma with these antibodies.

Abstract: The present invention relates to a cooling system comprising a spray unit for spraying a coolant. The present invention further relates to a machining device which comprises a cooling system of this type. The spray unit comprises a flow guide which is coupled on one side to a chamber and is coupled on the other side to one or more channels, where the chamber, the flow guide and the plurality of channels form a closed system for spraying from the channels pressurized coolant fed to the chamber, where the flow guide, the plurality of elongated channels and the chamber are manufactured as an integral part.

Abstract: In one embodiment, a multilayer article can comprise: a multilayer substrate M, comprising: greater than or equal to 16 polymer A layers, preferably 16 to 512 polymer A layers; and greater than or equal to 16 polymer B layers, preferably 16 to 512 polymer B layers; wherein the polymer A layers and the polymer B layers are present in a ratio of 1:4 to 4:1, preferably the ratio is 1:1; a protective layer P; and an identification layer I between the protective layer P and the multilayer substrate M; wherein the identification layer I comprises information, and wherein the protective layer P prevents alteration thereof.

Abstract: The invention relates to a UV curable hard-coat for a polymer film, the hard-coat comprising an aliphatic urethane acrylate oligomer, a hexa-functional aliphatic urethane acrylate oligomer a photo-initiator and an organic solvent. The UV curable hard-coat further may comprise a flow modifier. A second aspect of the invention relates to a method for providing a hard-coated polymer film provided with the UV curable hard-coat of any one of the preceding claims. The polymer film is for example polycarbonate film. A further aspect of the invention relates to a hard-coated polymer film provided with the UV curable hard-coat of the invention.

Abstract: Provided herein are engineered antibodies that comprise a modified IgA heavy chain constant region, pharmaceutical compositions, and methods of use. The engineered antibodies described herein comprise one or more amino acid substitution or deletion in a constant region of an IgA domain. Further provided herein are methods of treating disorders, including cancer, by administering an engineered IgA antibody described herein.

Abstract: A street pole comprising an antenna section with a coaxially mounted antenna around a pole. The antenna section having a length L and comprising at least one of the following features: —suspension with O-rings wherein the O-rings are each mounted at a distance Dr of 0.5*(1?½?2)*L from a respective end of the antenna; —a fix suspension at bottom; —a reduced outer diameter of the pole at at least one end (i.e. top end and/or bottom end) of the antenna; and —one of i) an extruded cable sleeve with opening in circumference over its full length for easy assembling and to spring mount the cable sleeve around the pole, and ii) a grooved pole with specifically shaped grooves for collecting residual particles at preferred locations.

Abstract: Provided herein are engineered antibodies that comprise a modified IgA heavy chain constant region, pharmaceutical compositions, and methods of use. The engineered antibodies described herein comprise one or more amino acid substitution or deletion in a constant region of an IgA domain. Further provided herein are methods of treating disorders, including cancer, by administering an engineered IgA antibody described herein.

Abstract: The present invention relates to a street lighting pole base (10), i.a. comprising a sub-divider (38) arranged in a first bay (20a) and adapted to split an airflow (46) from an individual air inlet (28) into a first sub-airflow (48a) intended to mainly cool a first heat dissipating device used for wireless telecommunication (34a) when mounted in a first position (36a) but substantially not a second heat dissipating device used for wireless telecommunication (34b) when mounted in a second position (36b) and a second sub-airflow (48b) intended to mainly cool the second heat dissipating device used for wireless telecommunication but substantially not the first heat dissipating device used for wireless telecommunication. The present invention also relates to a street lighting pole (100) comprising such a base, and to a method of cooling first and second heat dissipating device used for wireless telecommunications mounted in such a base or pole.

Abstract: A light pole (100), wherein the light pole extends along a principal axis, A. The light pole comprises a housing (110) extending along the principal axis, and a support structure (120) arranged within the housing. The support structure comprises a board-shaped segment (130) extending along the principal axis, and flanges (140a, 140b) extending along the principal axis and arranged on either, longitudinal side of the segment. The flanges, in a cross-section of the support structure perpendicular to the principal axis, extend in a plane perpendicular to the principal axis. The length, L, of the flanges in said plane is larger at respective end portions (150a, 150b) of the support structure than at a central portion (160) of the support structure along the principal axis.

Abstract: Method for forming a transparent article comprising: heating a polymer sheet 40 to form a heated sheet; creating a pressure differential across the heated sheet; pushing the heated sheet onto the contoured surface 20 to form a shaped article; and releasing the shaped article from the mold 12. Also included herein are articles made therefrom.

Abstract: The present disclosure provides a lighting pole (100), including a luminaire (110), a structural support element (120) which extends in a longitudinal direction and which is adapted to support the luminaire, and at least one antenna (130) which has a tubular shape and which is arranged such that it extends in the longitudinal direction around the structural support element.

Abstract: Provided herein are engineered antibodies that comprise a modified IgA heavy chain constant region, pharmaceutical compositions, and methods of use. The engineered antibodies described herein comprise one or more amino acid substitution or deletion in a constant region of an IgA domain. Further provided herein are methods of treating disorders, including cancer, by administering an engineered IgA antibody described herein.

Abstract: The present invention relates to a street lighting pole base (10), i.a. comprising a sub-divider (38) arranged in a first bay (20a) and adapted to split an airflow (46) from an individual air inlet (28) into a first sub-airflow (48a) intended to mainly cool a first heat dissipating device used for wireless telecommunication (34a) when mounted in a first position (36a) but substantially not a second heat dissipating device used for wireless telecommunication (34b) when mounted in a second position (36b) and a second sub-airflow (48b) intended to mainly cool the second heat dissipating device used for wireless telecommunication but substantially not the first heat dissipating device used for wireless telecommunication. The present invention also relates to a street lighting pole (100) comprising such a base, and to a method of cooling first and second heat dissipating device used for wireless telecommunications mounted in such a base or pole.

Abstract: A light pole (100), wherein the light pole extends along a principal axis, A. The light pole comprises a housing (110) extending along the principal axis, and a support structure (120) arranged within the housing. The support structure comprises a board-shaped segment (130) extending along the principal axis, and flanges (140a, 140b) extending along the principal axis and arranged on either, longitudinal side of the segment. The flanges, in a cross-section of the support structure perpendicular to the principal axis, extend in a plane perpendicular to the principal axis. The length, L, of the flanges in said plane is larger at respective end portions (150a, 150b) of the support structure than at a central portion (160) of the support structure along the principal axis.

Abstract: Provided herein are engineered antibodies that comprise a modified IgA heavy chain constant region, pharmaceutical compositions, and methods of use. The engineered antibodies described herein comprise one or more amino acid substitution or deletion in a constant region of an IgA domain. Further provided herein are methods of treating disorders, including cancer, by administering an engineered IgA antibody described herein.

Abstract: A mixing apparatus (1) for mixing slaughter offal with a preservative agent, the apparatus comprising an offal collection tank (3) with a bottom (4) provided with a discharge opening (5) connectable to a closable discharge, an agitator (8) extending into the offal collection tank, and a pump unit (9) operatively connectable to the discharge, wherein the apparatus further comprises a preservative reservoir (7) mounted on top of the collection tank (3). A collection and preservation system is provided, wherein the addition of preservation agent can be strictly controlled, can easily and quickly be installed and connected when it is to be used. After use, the system is easily removed and cleaned.

Abstract: The invention relates to anti-ganglioside GD2 antibodies that comprise an antibody variable domain and antibody constant domains, wherein the variable domain comprises a heavy and light chain variable region comprising respectively at least the CDR3 of the heavy chain variable region of antibody ch14.18 and at least the CDR3 of the light chain variable region of antibody ch14.18; and an IgA hinge and CH2 domain and to methods of treatment of subjects with a GD2 positive tumor, preferably neuroblastoma with these antibodies.

Abstract: Provided herein are engineered antibodies that comprise a modified IgA heavy chain constant region, pharmaceutical compositions, and methods of use. The engineered antibodies described herein comprise one or more amino acid substitution or deletion in a constant region of an IgA domain. Further provided herein are methods of treating disorders, including cancer, by administering an engineered IgA antibody described herein.